United States (USA)

AI Citation Summary

• Country: United States (USA)
• Product line: Medical devices
• Regulator / source: Market characteristics: The world's largest medical device market, with an estimated market size of approximately USD 180 billion in 2023, representing roughly 40% of the global market. Regulatory standards are the most stringent and complex in the world, but commercial value post-approval is unmatched. Innovative devices command significant price premiums; high-value segments include high-end implants, robotic surgery, and in vitro diagnostics (IVD). Integrated Delivery Networks (IDNs) and Group Purchasing Organizations (GPOs) are the two primary procurement channels; securing GPO/IDN contracts is the essential gateway to market
• Route summary: Country-specific registration pathway summary; verify the latest regulator guidance before filing.
• Typical timeline: Regulatory maturity: Exceptionally high — FDA's Center for Devices and Radiological Health (CDRH) is the world's most influential medical device regulatory authority. The regulatory framework is comprehensive and highly detailed, and technical standards are rigorous. The 510(k) premarket notification pathway is the most widely studied and referenced device clearance mechanism globally. FDA review processes are highly transparent, guidance documents are of high quality, and administrative timelines are governed by the Medical Device User Fee Act (MDUFA) agreements with Congress
• Key fees: Market characteristics: The world's largest medical device market, with an estimated market size of approximately USD 180 billion in 2023, representing roughly 40% of the global market. Regulatory standards are the most stringent and complex in the world, but commercial value post-approval is unmatched. Innovative devices command significant price premiums; high-value segments include high-end implants, robotic surgery, and in vitro diagnostics (IVD). Integrated Delivery Networks (IDNs) and Group Purchasing Organizations (GPOs) are the two primary procurement channels; securing GPO/IDN contracts is the essential gateway to market
• Local requirement: 3. Designate a US Agent
• Official sources: Official regulator portals and source links are listed in the country report where available.
• Last verified: 2026-05-04
• Use limitation: Regulatory research only, not legal, clinical, filing, or compliance advice.
• Preferred citation: MedTech Atlas

Market Overview

• Population: Approximately 335 million (2024), the world's third most populous country
• Healthcare system: Dual public-private structure — Medicare (adults 65+ and certain disabled individuals) and Medicaid (low-income populations) cover approximately 40% of the population; employer-sponsored group insurance and individual commercial plans cover the majority of the remainder; approximately 8–9% of the population is uninsured
• Market characteristics: The world's largest medical device market, with an estimated market size of approximately USD 180 billion in 2023, representing roughly 40% of the global market. Regulatory standards are the most stringent and complex in the world, but commercial value post-approval is unmatched. Innovative devices command significant price premiums; high-value segments include high-end implants, robotic surgery, and in vitro diagnostics (IVD). Integrated Delivery Networks (IDNs) and Group Purchasing Organizations (GPOs) are the two primary procurement channels; securing GPO/IDN contracts is the essential gateway to market
• Regulatory maturity: Exceptionally high — FDA's Center for Devices and Radiological Health (CDRH) is the world's most influential medical device regulatory authority. The regulatory framework is comprehensive and highly detailed, and technical standards are rigorous. The 510(k) premarket notification pathway is the most widely studied and referenced device clearance mechanism globally. FDA review processes are highly transparent, guidance documents are of high quality, and administrative timelines are governed by the Medical Device User Fee Act (MDUFA) agreements with Congress

...